Vaccination

Q&A: Examining low vaccine uptake among at-risk Canadians

As the flu season begins and the COVID-19 pandemic continues, pneumococcal vaccination is more important than ever to prevent disease and death from pneumonia and other forms of pneumococcal disease.

Vaccination

New vaccines and old can curb drug resistance

Trials of new vaccine candidates must be accelerated and existing vaccine use stepped up to prevent life-threatening infections that can no longer be beaten by antimicrobial medicines, the World Health Organization (WHO) ...

Diseases, Conditions, Syndromes

Vaccine narrows racial disparities in pneumococcal disease

In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the near elimination of ...

Diseases, Conditions, Syndromes

Survey: many U.S. adults not planning to get flu vaccine

(HealthDay)—Many U.S. adults, including some at the highest risk for the flu and pneumonia, do not plan to get preventive vaccines, according to a survey conducted by NORC at the University of Chicago on behalf of the National ...

Medications

Reevaluating pneumococcal vaccine guidance: An analysis

If mitigating racial disparities in those who contract pneumococcal diseases, such as meningitis and pneumonia, is a top public health priority, then recommending that all adults get a pneumococcal vaccine at age 50 would ...

page 2 from 7